Hydromadinone acetate

Hydromadinone acetate (developmental code name NSC-33170), also known as chloroacetoxyprogesterone (CAP), as well as 6α-chloro-17α-acetoxyprogesterone or 6α-chloro-17α-acetoxypregn-4-ene-3,20-dione, is a steroidal progestin of the 17α-hydroxyprogesterone group that was never marketed.[1][2] It is the C17α acetate ester of hydromadinone, which, similarly, was never marketed.[1]

Hydromadinone acetate
Clinical data
Other namesNSC-33170; Chloroacetoxyprogesterone; CAP; 6α-Chloro-17α-acetoxyprogesterone; 6α-Chloro-17α-acetoxypregn-4-ene-3,20-dione
Drug classProgestogen; Progestogen ester
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ECHA InfoCard100.124.835
Chemical and physical data
FormulaC23H31ClO4
Molar mass406.95 g·mol−1
3D model (JSmol)

See also

References

  1. Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 255–. ISBN 978-1-4757-2085-3.
  2. Negwer M, Scharnow H (2001). Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. p. 3723. ISBN 978-3-527-30247-5.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.